FDA Person
FDAIfechimere I. Okafor
View detailed information about Ifechimere I. Okafor, including compliance records, violations, and related data.
Person Profile
FDA investigator. Took part in 19 inspections of 19 companies, 2024–2026.
Inspections (19)
| Date | Company | Classification | Project area | Inspection |
|---|---|---|---|---|
| August 28, 2026 | Cosette Pharmaceuticals NC Laboratories, LLC | Not classified | Drug Quality Assurance | #1328404 |
| August 12, 2026 | Nitto Denko Avecia Inc. | NAI | Drug Quality Assurance | #1300758 |
| July 10, 2026 | Shine Spect USA, LLC | Not classified | Drug Quality Assurance | #1325866 |
| June 22, 2026 | Brigham and Women's Hospital | Not classified | Drug Quality Assurance | #1323146 |
| May 8, 2026 | Perrigo New York, Inc. | VAI | Drug Quality Assurance | #1316190 |
| April 10, 2026 | The Tender Corporation | Not classified | Drug Quality Assurance | #1301864 |
| March 10, 2026 | Lyne Laboratories, Inc. | VAI | Drug Quality Assurance | #1306884 |
| January 23, 2026 | Vantage Specialty Ingredients, Inc. | Not classified | #1299546 | |
| November 21, 2025 | Catalent Pharma Solutions, LLC | Not classified | #1285382 | |
| September 29, 2025 | UL Verification Services | NAI | Drug Quality Assurance | #1286910 |
| August 14, 2025 | Genzyme Corporation | NAI | Drug Quality Assurance | #1281578 |
| July 25, 2025 | Avista Pharma Solutions, Inc. | VAI | Drug Quality Assurance | #1278383 |
| June 18, 2025 | Seaway Pharma Inc. | OAI | Drug Quality Assurance | #1272511 |
| March 20, 2025 | G. C. Hanford Manufacturing Co | OAI | Drug Quality Assurance | #1264589 |
| December 20, 2024 | Chartwell Pharmaceuticals Carmel LLC | OAI | Generic Drug Evaluation | #1257461 |
| September 20, 2024 | RiconPharma LLC | VAI | Drug Quality Assurance | #1249674 |
| July 29, 2024 | Denison Pharmaceuticals, LLC | OAI | Drug Quality Assurance | #1240591 |
| May 30, 2024 | Equibal Inc | VAI | Drug Quality Assurance | #1239888 |
| April 12, 2024 | Primera Analytical Solutions Corp. | VAI | Drug Quality Assurance | #1235710 |
Documents (11)
- 483 · Chartwell Pharmaceuticals Carmel LLC · December 20, 2024
- EIR · Avista Pharma Solutions, Inc. · July 25, 2025
- 483 · G. C. Hanford Manufacturing Co · March 20, 2025
- 483 · Primera Analytical Solutions Corp. · April 12, 2024
- 483 · Denison Pharmaceuticals, LLC · July 29, 2024
- 483 · Seaway Pharma Inc. · June 18, 2025
- 483 · Avista Pharma Solutions, Inc. · July 25, 2025
- 483 · Vantage Specialty Ingredients, Inc. · January 23, 2026
- 483 · Perrigo New York, Inc. · May 8, 2026
- 483 · Shine Spect USA, LLC · July 10, 2026
- 483 · Brigham and Women's Hospital · June 22, 2026
Frequently inspected with (10)
Edmund F. Mrak
Investigator
4 shared
Anthony J. Donato
investigator
2 shared
Armen H. Youssoufian
2 shared
Daniel L. Zheng
M.S., Consumer Safety Officer at FDA
2 shared
Lori M. Newman
Deputy Director
2 shared
Alisha B. Patel
1 shared
Andrew O. Ejiofor
1 shared
Christian F. Gomez Lugo
1 shared
Elena N. Thomas
1 shared
Erik W. Koester
Investigator
1 shared
Person Information
Name
Ifechimere I. Okafor
Title
investigator
Role
COMPANY REP
ID: c48399bf-47d9-4562-9130-1e6731eca07d
Get More Insights
Access our comprehensive quality intelligence platform to analyze patterns, track compliance trends, and stay ahead of regulatory changes.
1.5M+ regulatory data points
Real-time compliance monitoring
Interactive analytics dashboard
Looking for more people? Our platform provides access to thousands of FDA people with advanced search and filtering capabilities.
Transform Regulatory Data into Actionable Intelligence
Join leading pharmaceutical and medical device companies who trust KeyPedia for their regulatory compliance needs.